284 related articles for article (PubMed ID: 33987346)
1. Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.
Alemany M; Domènech M; Argyriou AA; Vilariño N; Majós C; Naval-Baudin P; Lucas A; Palmero R; Simó M; Nadal E; Bruna J
Ann Transl Med; 2021 Apr; 9(8):648. PubMed ID: 33987346
[TBL] [Abstract][Full Text] [Related]
2. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.
Ren Y; Wang SB; Zhou L; Liu SQ; Du LY; Li T; Jiang MQ; Lei KJ; Tan BX; Jia YM
Technol Cancer Res Treat; 2021; 20():15330338211011968. PubMed ID: 33955301
[TBL] [Abstract][Full Text] [Related]
3. EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.
Jiang T; Su C; Li X; Zhao C; Zhou F; Ren S; Zhou C; Zhang J
J Thorac Oncol; 2016 Oct; 11(10):1718-28. PubMed ID: 27237825
[TBL] [Abstract][Full Text] [Related]
4. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of brain metastases from lung cancer according to histological type: Pretreatment evaluation and survival following whole-brain radiotherapy.
Komatsu T; Kunieda E; Oizumi Y; Tamai Y; Akiba T
Mol Clin Oncol; 2013 Jul; 1(4):692-698. PubMed ID: 24649230
[TBL] [Abstract][Full Text] [Related]
8. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
9. Best Supportive Care
Li H; Xue R; Yang X; Han S; Yang W; Song X; Zhang X; Cao J; Jia S; Wang W; Lian J
Front Oncol; 2021; 11():568568. PubMed ID: 33732638
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: A case report and literature review.
He G; Xiao X; Zou M; Zhang C; Xia S
Medicine (Baltimore); 2016 Aug; 95(32):e4401. PubMed ID: 27512852
[TBL] [Abstract][Full Text] [Related]
11. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
12. Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study.
Liao G; Qian Y; Arooj S; Zhao Z; Yan M; Li Z; Yang H; Zheng T; Li G; Li X; Khan M
Front Oncol; 2021; 11():742971. PubMed ID: 34745964
[TBL] [Abstract][Full Text] [Related]
13. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases.
Stefanou D; Stamatopoulou S; Sakellaropoulou A; Akakios G; Gkiaouraki M; Gkeka D; Prevezanou M; Ardavanis A
Oncol Lett; 2016 Dec; 12(6):4635-4642. PubMed ID: 28101218
[TBL] [Abstract][Full Text] [Related]
15. Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases.
Yu F; Ni J; Zeng W; Zhou Y; Guo T; Zeng Y; Zhao Y; Li S; Li Y; Yang X; Zou L; Wang S; Liu Q; Li Y; Chu L; Chu X; Ye L; Yu W; Zhu Z
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):804-815. PubMed ID: 34058255
[TBL] [Abstract][Full Text] [Related]
16. Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis.
Lu F; Hou Y; Xia Y; Li L; Wang L; Cao K; Chen H; Chang L; Li W
Cancer Manag Res; 2019; 11():4255-4272. PubMed ID: 31190992
[No Abstract] [Full Text] [Related]
17. Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma.
Li C; Guo J; Zhao L; Hu F; Nie W; Wang H; Zheng X; Shen Y; Gu P; Zhang Y; Zhang X
Cancer Manag Res; 2019; 11():3433-3443. PubMed ID: 31114377
[No Abstract] [Full Text] [Related]
18. Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities.
Chu L; Ni J; Yang X; Tong T; Wang J; Yin F; Li R; Li Y; Zou L; Li Y; Xie C; Li G; Zhu Z
J Cancer; 2019; 10(26):6660-6665. PubMed ID: 31777594
[No Abstract] [Full Text] [Related]
19. Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.
Dinglin XX; Huang Y; Liu H; Zeng YD; Hou X; Chen LK
J Neurooncol; 2013 May; 112(3):461-6. PubMed ID: 23420398
[TBL] [Abstract][Full Text] [Related]
20. WBRT for brain metastases from non-small cell lung cancer: for whom and when?-Contemporary point of view.
Sas-Korczynska B; Rucinska M
J Thorac Dis; 2021 May; 13(5):3246-3257. PubMed ID: 34164217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
